Literature DB >> 5303008

Treatment of bronchopulmonary aspergillosis with observations on the use of natamycin.

A H Henderson, J E Pearson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5303008      PMCID： PMC471841          DOI： 10.1136/thx.23.5.519

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  13 in total

1.  THE TREATMENT OF BRONCHOPULMONARY MYCOSES WITH A NEW ANTIBIOTIC--PIMARICIN.

Authors:  G EDWARDS; C J LATOUCHE
Journal:  Lancet       Date:  1964-06-20       Impact factor: 79.321

2.  Current status of amphotericin B in the treatment of the systemic fungus infections.

Authors:  V D NEWCOMER; T H STERNBERG; E T WRIGHT; R M REISNER
Journal:  J Chronic Dis       Date:  1959-04

3.  Bronchopulmonary aspergilloma.

Authors:  C L ROBINSON; A R McPHERSON
Journal:  Can J Surg       Date:  1962-10       Impact factor: 2.089

4.  The pathogenetic spectrum of aspergillosis.

Authors:  J H SEABURY; M SAMUELS
Journal:  Am J Clin Pathol       Date:  1963-07       Impact factor: 2.493

5.  Invasive primary aspergillosis of the lung with cerebral metastasis and complete recovery.

Authors:  P E CONEN; G R WALKER; J A TURNER; P FIELD
Journal:  Dis Chest       Date:  1962-07

6.  Pulmonary resection for localized aspergillosis.

Authors:  D V PECORA; M W TOLL
Journal:  N Engl J Med       Date:  1960-10-20       Impact factor: 91.245

7.  Pulmonary aspergillosis. A survey of its occurrence in patients with chronic lung disease and a discussion of the significance of diagnostic tests.

Authors:  A H Henderson; M P English; R J Vecht
Journal:  Thorax       Date:  1968-09       Impact factor: 9.139

8.  Allergic aspergillosis: review of 32 cases.

Authors:  A H Henderson
Journal:  Thorax       Date:  1968-09       Impact factor: 9.139

9.  Aspergilloma following pulmonary tuberculosis.

Authors:  J W Fraser
Journal:  Scott Med J       Date:  1965-08       Impact factor: 0.729

10.  Pulmonary hypersensitivity disease due to inhaled organic antigens.

Authors:  J Pepys
Journal:  Postgrad Med J       Date:  1966-11       Impact factor: 2.401
View more
  10 in total

1.  Corticosteroid treatment and prognosis in pulmonary eosinophilia.

Authors:  S Capewell; B J Chapman; F Alexander; A P Greening; G K Crompton
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

2.  Disseminated aspergillosis.

Authors:  B J Burke; F K Storring; T E Parry
Journal:  Thorax       Date:  1970-11       Impact factor: 9.139

3.  Farmer's lung and pulmonary aspergillosis.

Authors: 
Journal:  Br Med J       Date:  1968-12-07

4.  Indications and outcome of surgery for pulmonary aspergilloma.

Authors:  R el Oakley; M Petrou; P Goldstraw
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

5.  Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis.

Authors:  D C Currie; C Lueck; H J Milburn; C Harvey; J L Longbottom; J H Darbyshire; A J Nunn; P J Cole
Journal:  Thorax       Date:  1990-06       Impact factor: 9.139

6.  Surgical treatment of pulmonary aspergilloma.

Authors:  H Soltanzadeh; A R Wychulis; F Sadr; P J Bolanowski; W E Neville
Journal:  Ann Surg       Date:  1977-07       Impact factor: 12.969

7.  Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment.

Authors:  J Jewkes; P H Kay; M Paneth; K M Citron
Journal:  Thorax       Date:  1983-08       Impact factor: 9.139

8.  Trial of ketoconazole in non-invasive pulmonary aspergillosis.

Authors:  D J Shale; J A Faux; D J Lane
Journal:  Thorax       Date:  1987-01       Impact factor: 9.139

9.  Management of pulmonary aspergilloma in the presence of active tuberculosis.

Authors:  A O Adeyemo; E O Odelowo; D I Makanjuola
Journal:  Thorax       Date:  1984-11       Impact factor: 9.139

10.  Cavernostomy x resection for pulmonary aspergilloma: a 32-year history.

Authors:  Jorge Ms Cesar; Jose S Resende; Nilson F Amaral; Carla Ms Alves; Alyne F Vilhena; Frederico L Silva
Journal:  J Cardiothorac Surg       Date:  2011-10-05       Impact factor: 1.637
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.